Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Milligan

Showing results (121-130 of 125) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 125 results.
Lancet (London, England)|February 9, 2000
Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trialL von Seidlein, P Milligan, M Pinder, et al.
Clinical and Experimental Immunology|January 24, 2004
Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The GambiaM Pinder, W H H Reece, M Plebanski, et al.
Vaccine|July 18, 2006
Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian menE B Imoukhuede, T Berthoud, P Milligan, et al.
Environmental Research|November 14, 1997
The assessment of biomarkers to detect nephrotoxicity using an integrated databaseS A Taylor, I D Chivers, R G Price, et al.
The American Journal of Medicine|August 11, 2020
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) InfectionPeter A McCullough, Ronan J Kelly, Gaetano Ruocco, et al.
Pageof 13

Showing results (121-130 of 125) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
Lancet (London, England)|February 9, 2000
Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trialL von Seidlein, P Milligan, M Pinder, et al.
Clinical and Experimental Immunology|January 24, 2004
Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The GambiaM Pinder, W H H Reece, M Plebanski, et al.
Vaccine|July 18, 2006
Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian menE B Imoukhuede, T Berthoud, P Milligan, et al.
Environmental Research|November 14, 1997
The assessment of biomarkers to detect nephrotoxicity using an integrated databaseS A Taylor, I D Chivers, R G Price, et al.
The American Journal of Medicine|August 11, 2020
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) InfectionPeter A McCullough, Ronan J Kelly, Gaetano Ruocco, et al.
Pageof 13